Specifically, MDM2 expression or the presence of the MDM2 SNP309 polymorphism, which causes increased expression of the MDM2 gene, correlated negatively with outcome in patients with mesothelioma [53, 54]. This evidence concerns the gene MDM2 and mesothelioma.